Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02520297 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study of TRV130 for the Treatment of Fracture Pain
A Phase 2 study, sponsored by Trevena.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT02520297 is a Phase 2 study that was terminated before completion, run by Trevena. The registered enrollment target is 1 participants.
The verdict
NCT02520297, a Phase 2 study, was terminated before completion, sponsored by Trevena.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the analgesic efficacy of TRV130 for moderate to severe acute pain in patients presenting to the emergency department (ED) with a suspected/known, unilateral, closed long bone fracture.
Interventions
- DRUG TRV130
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-10-20 |
| Est. Completion | 2015-10-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02520297
The ClinicalTrials.gov registry entry for NCT02520297 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trevena, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TRV130 is the first listed.
NCT02520297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02520297 about?
NCT02520297 is a clinical study titled "A Pilot Study of TRV130 for the Treatment of Fracture Pain". The primary objective is to evaluate the analgesic efficacy of TRV130 for moderate to severe acute pain in patients presenting to the emergency department (ED) with a suspected/known, unilateral, closed long bone fracture.
What is the current status of trial NCT02520297?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2015-10-20. Estimated completion is 2015-10-23.
What interventions are being tested in trial NCT02520297?
The interventions under investigation include: TRV130 (DRUG).
Who is sponsoring clinical trial NCT02520297?
This trial is sponsored by Trevena, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.